SCYX
SCYX
NASDAQ · Pharmaceuticals

Scynexis Inc

$3.95
+0.15 (+3.95%)
As of Jun 23, 5:25 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +105.6% upside
Low Target $6.66
Average Target $8.12
High Target $12.47
Current Price $3.95
Current
$3.95
Target
$8.12
$6.66 $8.12 avg $12.47
Scenario Analysis
Bear Case
$6.66
68.6%
Low target
Base Case
$8.12
+105.6%
Avg target
Bull Case
$12.47
+215.7%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$10.48
-62.3% from high
52-Week Low
$3.80
+3.9% from low
Target vs 52W High
$8.12
-22.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%